Predictor for an Additional Benefit of Inhaled Corticosteroid in Patients Treated With Tiotropium for COPD
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
Study purpose is to evaluate if subjects with chronic obstructive pulmonary disease (COPD)
are more likely to be responsive to additional inhaled corticosteroids if they have a
positive response to hyperosmolar challenge with mannitol than if their response is negative.
Phase:
Phase 4
Details
Lead Sponsor:
Cantonal Hosptal, Baselland University Hospital, Basel, Switzerland